期刊
MEDICAL CLINICS OF NORTH AMERICA
卷 96, 期 6, 页码 1079-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2012.08.006
关键词
Antimicrobial therapy; Multidrug resistance; Streptococcus pneumoniae; Methicillin-resistant Staphylococcus aureus; Enterococcus; Pseudomonas aeruginosa; Group A beta-hemolytic Streptococcus
Life-threatening infectious disease emergencies require immediate, aggressive parenteral administration of antimicrobial agents to ensure high bactericidal concentrations of drug at the site of infection. Initial treatment is an empiric approach using of broad-spectrum bactericidal agents aimed at eradicating the presumed infecting organism(s), which potentially could be multidrug resistant. Once an infection is under control and the culture and sensitivity results are reported, it is important to switch to the most narrow-spectrum agent possible. This action will decrease the potential for adverse drug effects and the risk of development of antibiotic-induced resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据